• market

  PRIVATE

• industry

  Biotechnology

• website

  proniras.com

• crunchbase

  proniras-corp

Proniras Corporation is a clinical-stage biotechnology company developing novel small-molecule therapeutics for the treatment of substance use and specialty central nervous system disorders. Its lead program, PRN-001-01 (tezampanel), is being clinically developed as a treatment option for opioid withdrawal and related disorders of addiction.